Notable 52-Week Highs and Lows of the Day 12/21: (CTAS) (CVS) (AMGN) High; (AMGN) (VECO) (CREE) Low

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.

52-Week High:

• Cintas Corporation (Nasdaq: CTAS) high of $34.62. Chintas moving about 10.7 percent Wednesday on earnings. Yesterday, the company reported second-quarter earnings of 57 cents per share on revenue of $1.02 billion, versus consensus views calling for earnings of 48 cents per share and revenue of $1.0 billion. Looking ahead, the company raised its fiscal 2012 earnings outlook from a range of $1.97 to $2.05 to a range of $2.16 to $2.20 and revs from $4.00 to $4.10 billion to $4.075 to $4.125 billion. The Street was looking for EPS of $2.03 and revs of $4.08 billion.
  
  
• VS Caremark Corporation (NYSE: CVS) high of $40.59. CVS is continuing to move higher Wednesday, keeping the momentum going from Tuesday when it reaffirmed its fiscal 2011 outlook, and issued fiscal 2012 guidance calling for earnings of $3.15 to $3.25 per share, versus $3.21 expected on the Street. Free cash flow will also be $4.3 to $4.6 billion, CVS notes. CVS moved up about 2 percent Wednesday.
  
  
• Amgen Inc. (Nasdaq: AMGN) high of $63.22. Amgen moving higher again today, following a 1.6 percent gain Tuesday on a collaboration with Watson Pharma (NYSE: WPI) for to develop and commercialize, on a worldwide basis, several oncology antibody biosimilar medicines.

52-Week Low:

• Salesforce.com (NYSE: CRM) low of $94.09. With segment leader Oracle (Nasdaq: ORCL) reporting an earnings miss, investors are taking other tech names down in reevaluation. Salesforce is down nearly 10 percent Wednesday.
  
  
• Veeco Instruments (Nasdaq: VECO) low of $20.82. Veeco lower with the LED sector Wednesday. Needham & Company started coverage with a Hold rating, but commented that MOCVD overcapacity will persist for the next 12-18 months.
  
  
• Cree, Inc. (Nasdaq: CREE) low of $20.25. Cree just slightly lower, but it has been trending lower since the start of November. The stock is about 30 percent lower over the last two-months, after closing at $30.57 on November 4th.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Needham Reiterates Buy Rating on Veeva Systems (VEEV)
• H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance